Ye X - Search Results

1

The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.

Chen Z, Li Z, Niu X, Ye X, Yu Y, Lu S, Chen Z. Chen Z, et al. Among authors: ye x. Mutagenesis. 2011 May;26(3):437-46. doi: 10.1093/mutage/ger002. Epub 2011 Mar 14. Mutagenesis. 2011. PMID: 21402622

2

A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.

Niu X, Li H, Chen Z, Liu Y, Kan M, Zhou D, Li Z, Ye X, Shen S, Lv C, Lu S. Niu X, et al. Among authors: ye x. J Thorac Oncol. 2012 Nov;7(11):1668-75. doi: 10.1097/JTO.0b013e318267cf5b. J Thorac Oncol. 2012. PMID: 23059779 Free article.

3

Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.

Chen Z, Xu L, Ye X, Shen S, Li Z, Niu X, Lu S. Chen Z, et al. Among authors: ye x. PLoS One. 2013 Apr 16;8(4):e61008. doi: 10.1371/journal.pone.0061008. Print 2013. PLoS One. 2013. PMID: 23613771 Free PMC article. Review.

4

Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells.

Chen Z, Niu X, Li Z, Yu Y, Ye X, Lu S, Chen Z. Chen Z, et al. Among authors: ye x. Cell Biochem Funct. 2011 Mar;29(2):142-8. doi: 10.1002/cbf.1734. Epub 2011 Feb 1. Cell Biochem Funct. 2011. PMID: 21287580

5

The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.

Chen Z, Ye X, Tang N, Shen S, Li Z, Niu X, Lu S, Xu L. Chen Z, et al. Among authors: ye x. Br J Pharmacol. 2014 Jul;171(13):3196-211. doi: 10.1111/bph.12661. Br J Pharmacol. 2014. PMID: 24571482 Free PMC article.

6

The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2.

Li Z, Xu L, Tang N, Xu Y, Ye X, Shen S, Niu X, Lu S, Chen Z. Li Z, et al. Among authors: ye x. FEBS Lett. 2014 Aug 25;588(17):3000-7. doi: 10.1016/j.febslet.2014.05.057. Epub 2014 Jun 10. FEBS Lett. 2014. PMID: 24928441 Free article.

7

Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 Studies.

Lu S, Yu Y, Chen Z, Ye X, Li Z, Niu X. Lu S, et al. Among authors: ye x. Lung. 2015 Oct;193(5):805-14. doi: 10.1007/s00408-015-9758-y. Epub 2015 Jun 29. Lung. 2015. PMID: 26119960 Review.

8

Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment.

Niu X, Liu F, Zhou Y, Zhou Z, Zhou D, Wang T, Li Z, Ye X, Yu Y, Weng X, Zhang H, Ye J, Liao M, Liu Y, Chen Z, Lu S. Niu X, et al. Among authors: ye x, ye j. Clin Cancer Res. 2017 Sep 1;23(17):5003-5014. doi: 10.1158/1078-0432.CCR-16-2688. Epub 2017 May 10. Clin Cancer Res. 2017. PMID: 28490462

9

Prognostic significance of anaplastic lymphoma kinase rearrangement in patients with completely resected lung adenocarcinoma.

Liu Y, Ye X, Yu Y, Lu S. Liu Y, et al. Among authors: ye x. J Thorac Dis. 2019 Oct;11(10):4258-4270. doi: 10.21037/jtd.2019.09.65. J Thorac Dis. 2019. PMID: 31737311 Free PMC article.

10

[Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Chen ZW, Ye XY, Lu S. Xu YH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):716-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173920 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,294 results

Search Page

Filters